According to the status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), the subtypes can be defined as normal-like breast cancer, luminal A breast cancer, luminal B breast cancer, HER2-enriched breast cancer and triple-negative/basal-like breast cancer [1]. This evidence concerns the gene ESR1 and breast cancer.